PRE: Prenetics Global Ltd Sotuvga nisbatan narx

Prenetics Global Ltd (PRE) tovar belgisi

Danny Young'ning tezkor kengayishi ma'lum operatsion xatarlarni yuzaga keltirmoqda; biroq, GURU.Markets kunlik grafigidagi daromad koeffitsiyenti dinamikasi, u yerda joriy qiymat 1.80 ni tashkil etadi, aktivning barqarorligini tasdiqlaydi. Prenetics Global (PRE) Osiyodagi DNK skriningi sohasida yetakchiligini saqlab qolmoqda va suyuq sherikliklar tomonidan qo'llab-quvvatlanadigan erta saraton diagnostikasiga yo'nalgan strategik o'zgarishi tebranishlarni neytrallab, shaxsiy tibbiyot sohasidagi global ishtirokchi sifatidagi maqomini mustahkamlamoqda.

PRE (Prenetics Global) P/S multiplikatori tarixi 28.04.2023dan 13.11.2026gacha

Prenetics Global (PRE) kompaniyasining tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:PRE (Prenetics Global Limited)
Prenetics Global Limited brendining mahsuloti

P/S koeffitsiyenti Prenetics Global (PRE) kompaniyasining sotuvlarining har bir dollari uchun bozor qiymatini aks ettiradi va aktivning tarixiy medianlarga nisbatan haddan tashqari sotib olingan holatini baholash imkonini beradi. Aksiyaga nisbatan narx-sotuvlar koeffitsiyentini tahlil qilish orqali investor joriy kapitalizatsiyani optimallashtirilgan diagnostika tizimi logistikasining samaradorligi bilan solishtirishi mumkin, bu esa qimmatqog'ni spekulyativ pufakning cho'qqisida sotib olishdan qochish va chuqur pasayishlarning oldini olish imkonini beradi.

Prenetics Global raqobatchilari

A (agilent.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DGX (Quest Diagnostics Incorporated)|Illumina Inc (ILMN) - Sotuvga nisbatan narx|EXAS - Narxning daromadga nisbati|RVTY (Revvity Corp) - Kapitalizatsiya va daromad nisbati|BIO: P/S multiplikatori|Sotuvga nisbatan narx anbio.com (NNNN)|Kapitalizatsiyaning daromadga nisbati SHC|QDEL (Quidel Corporation) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori OPK|Narx/daromad koeffitsiyenti CareDx Health|P/S multiplikatori MRVI (Maravai LifeSciences)|FLGT - Kapitalizatsiyaning daromadga nisbati|LAB - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Cytek Biosciences Inc CTKB|OSUR (OraSure Technologies Inc) - Kapitalizatsiyaning daromadga nisbati|Exagen - Bozor kapitallashuvining daromadga nisbati|MDXH (MDxHealth SA) - P/S multiplikatori|LUCD - Narx/daromad multiplikatori|Narxning daromadga nisbati Insight Molecular Diagnostics (IMDX)|Narxning daromadga nisbati TRIB (trinitybiotech.com)|Narxning daromadga nisbati ProPhase PRPH|Ainos Corporation (AIMD) - Sotuvga nisbatan narx|Co-Diagnostics, Inc. - P/S multiplikatori|HSCS: Narxning daromadga nisbati|BMRA: P/S multiplikatori|Cardio Diagnostics Holdings (CDIO) - P/S multiplikatori|Narxning daromadga nisbati Onconetix Corp|Narxning daromadga nisbati VRAX|Narxning daromadga nisbati Bluejay Diagnostics (BJDX)|AWH: Narxning sotuvga nisbati|Narxning daromadga nisbati Accelerate Diagnostics, Inc. AXDX|Bozor kapitallashuvining daromadga nisbati CNTG|Enzo - P/S multiplikatori|Sotuvga nisbatan narx Fresh2 Group Limited|gtglabs.com (GENE) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati 23andme.com|PMD (Psychemedics Corporation) - P/S multiplikatori